AAAAAA

   
Results: 1-8 |
Results: 8
Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate
Authors: Shen, XZ Lagergard, T Yang, YH Lindblad, M Fredriksson, M Wallerstrom, G Holmgren, J
Citation: Xz. Shen et al., Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate, VACCINE, 19(25-26), 2001, pp. 3360-3368
Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugate vaccines prepared by different methods for intranasal immunization
Authors: Shen, XZ Lagergard, T Yang, YH Lindblad, M Fredriksson, M Holmgren, J
Citation: Xz. Shen et al., Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugate vaccines prepared by different methods for intranasal immunization, INFEC IMMUN, 69(1), 2001, pp. 297-306
Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice
Authors: Rask, C Holmgren, J Fredriksson, M Lindblad, M Nordstrom, I Sun, JB Czerkinsky, C
Citation: C. Rask et al., Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice, CLIN EXP AL, 30(7), 2000, pp. 1024-1032
Mucosal and systemic antibody responses after peroral or intranasal immunization: Effects of conjugation to enterotoxin B subunits and/or of co-administration with free toxin as adjuvant
Authors: Rask, C Fredriksson, M Lindblad, M Czerkinsky, C Holmgren, J
Citation: C. Rask et al., Mucosal and systemic antibody responses after peroral or intranasal immunization: Effects of conjugation to enterotoxin B subunits and/or of co-administration with free toxin as adjuvant, APMIS, 108(3), 2000, pp. 178-186
Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization
Authors: Shen, XZ Lagergard, T Yang, YH Lindblad, M Fredriksson, M Holmgren, J
Citation: Xz. Shen et al., Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization, VACCINE, 19(7-8), 2000, pp. 850-861
Cross-reactive T-helper responses in patients infected with different subtypes of human immunodeficiency virus type 1
Authors: Leandersson, AC Gilljam, G Fredriksson, M Hinkula, J Alaeus, A Lidman, K Albert, J Bratt, G Sandstrom, E Wahren, B
Citation: Ac. Leandersson et al., Cross-reactive T-helper responses in patients infected with different subtypes of human immunodeficiency virus type 1, J VIROLOGY, 74(10), 2000, pp. 4888-4890
Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera term B subunit conjugate vaccine
Authors: Shen, XZ Lagergard, T Yang, YH Lindblad, M Fredriksson, M Holmgren, J
Citation: Xz. Shen et al., Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera term B subunit conjugate vaccine, INFEC IMMUN, 68(10), 2000, pp. 5749-5755
Periodontitis increases chemiluminescence of the peripheral neutrophils independently of priming by the preparation method
Authors: Fredriksson, M Gustafsson, A Asman, B Bergstrom, K
Citation: M. Fredriksson et al., Periodontitis increases chemiluminescence of the peripheral neutrophils independently of priming by the preparation method, ORAL DIS, 5(3), 1999, pp. 229-233
Risultati: 1-8 |